The primary indication for therapy is paramountpatients using these medications for type 2 diabetes management typically require long-term treatment as part of comprehensive disease management, whereas those using GLP-1 agents solely for weight management may have more flexibility depending on their response and circumstances
Below is the chart listing Novo Nordisks semaglutide patents listed in the Orange Book
Both products contain tirzepatide, a dual GIP and GLP-1 receptor agonist with a 5-day half-life
He took it again for three years when he started bodybuilding
Clinical trials suggest Orforglipron may provide greater weight loss and blood sugar improvements compared to oral semaglutide, along with easier administration
While clinical trial data confirms the effectiveness of ongoing treatment, real world practice highlights a more complex picture - patients and providers are experimenting with medication tapering, spacing, switching, and other adaptations to make therapy more sustainable